Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide

Asia-Pacific Journal of Clinical Oncology

Volumn 7, Issue 3, 2011, Pages 270-275

  Lin, Feng ^a   Wang, Qiong ^a   Yu, Wenxi ^a   Tang, Lina ^a   Zheng, Shuier ^a   Sun, Yuanjue ^a   Shen, Zan ^a   Yao, Yang ^a   Dong, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

High dose chemotherapy; Osteosarcoma; Side effect; Therapeutic efficacy; Toxic

Indexed keywords

CISPLATIN; DOXORUBICIN; FOLINATE CALCIUM; IFOSFAMIDE; MESNA; METHOTREXATE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHINESE; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; FEMALE; HAIR LOSS; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROTOXICITY; OSTEOSARCOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHINA; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; IFOSFAMIDE; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; OSTEOSARCOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052222324     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2011.01406.x     Document Type: Article

References (16)

1. Zhang Q, Niu XH, Cai XB. The analysis of the factors related to the local recurrence of osteosarcoma primarily occurred in the limbs. Chin J Surg 2007; 45: 1114-7.
2. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
3. Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 1972; 30: 1627-31.
4. Jaffe N. Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res 2010; 152: 239-62.
5. Bielack S, Carrle D, Casali PG. Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 (Suppl. 4): iv137-iv139.
6. Ferrari S, Smeland S, Mercuri M etal. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845-52.
7. Bruland OS, Bauer H, Alvegaard T, Smeland S. Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience. Cancer Treat Res 2010; 152: 309-18.
8. Ferrari S, Palmerini E, Staals EL, Mercuri M, Franco B, Picci P. The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli Experience. Impact on the future. Cancer Treat Res 2010; 152: 275-87.
9. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-30.
10. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27year experience at Rizzoli Institute, Italy. Eur J Cancer 2005; 41: 2836-45.
11. Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA. High dose ifosfamide in combination with high dose methotrexate, Adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother 2002; 14: 198-206.
12. Lin F, Yao Y, Tang LN etal. Relationship of serum methoteexate concentration in high-dose methotrxate chemotherapy to prognosis and tolerability: a prospective cohort study in Chinese adults with osteosarcoma. Curr Ther Res 2009; 70: 150-61.
13. Eselgrim M, Grunert H, Kühne T etal. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatr Blood Cancer 2006; 47: 42-50.
14. Goorin AM, Perez-Atayde A, Gebhardt M etal. Weekly high dose methotrexate and doxorubicin for osteosarcoma: the Dana Farber Cancer Institute/The Children's Hospital Study III. J Clin Oncol 1987; 5: 1178-84.
15. Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009; 10: 82-93.
16. Tan ML, Choonq PF, Dass CR. Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biol Ther 2009; 8: 106-17.